(MCS) Marcus - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5663301068
Stock: Theaters, Hotels, Resorts, Laundry
Total Rating 49
Risk 68
Buy Signal -0.16
| Risk 5d forecast | |
|---|---|
| Volatility | 29.4% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -7.27 |
| Character TTM | |
|---|---|
| Beta | 0.608 |
| Beta Downside | 1.058 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.14% |
| CAGR/Max DD | 0.14 |
EPS (Earnings per Share)
Revenue
Description: MCS Marcus March 04, 2026
Marcus Corporation operates two primary business segments: theaters and hotels. The company operates movie theaters under several brands, including Marcus Theatres and Movie Tavern by Marcus.
Its hotel segment includes ownership and management of full-service hotels and resorts. The hospitality industry is characterized by cyclical demand, influenced by economic conditions and travel trends.
Additionally, Marcus Corporation provides hospitality management services, including for condominium hotels and vacation ownership developments. This business model diversifies revenue streams beyond direct ownership.
For more detailed financial analysis, ValueRay offers comprehensive data on MCS.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 12.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.27 > 1.0 |
| NWC/Revenue: -13.03% < 20% (prev -10.31%; Δ -2.73% < -1%) |
| CFO/TA 0.08 > 3% & CFO 84.2m > Net Income 12.7m |
| Net Debt (199.4m) to EBITDA (90.4m): 2.21 < 3 |
| Current Ratio: 0.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.8m) vs 12m ago -3.14% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 73.67% > 50% (prev 70.42%; Δ 3.25% > 0%) |
| Interest Coverage Ratio: 1.76 > 6 (EBITDA TTM 90.4m / Interest Expense TTM 11.5m) |
Altman Z'' 0.92
| A: -0.10 (Total Current Assets 64.6m - Total Current Liabilities 163.4m) / Total Assets 1.01b |
| B: 0.26 (Retained Earnings 268.6m / Total Assets 1.01b) |
| C: 0.02 (EBIT TTM 20.2m / Avg Total Assets 1.03b) |
| D: 0.54 (Book Value of Equity 300.9m / Total Liabilities 557.2m) |
| Altman-Z'' Score: 0.92 = BB |
Beneish M -3.66
| DSRI: 0.86 (Receivables 19.1m/21.5m, Revenue 758.5m/735.6m) |
| GMI: 0.38 (GM 102.6% / 39.07%) |
| AQI: 1.15 (AQ_t 0.11 / AQ_t-1 0.09) |
| SGI: 1.03 (Revenue 758.5m / 735.6m) |
| TATA: -0.07 (NI 12.7m - CFO 84.2m) / TA 1.01b) |
| Beneish M-Score: -3.66 (Cap -4..+1) = AAA |
What is the price of MCS shares?
As of March 07, 2026, the stock is trading at USD 17.36 with a total of 134,143 shares traded.
Over the past week, the price has changed by +3.15%, over one month by +11.71%, over three months by +11.85% and over the past year by +6.36%.
Over the past week, the price has changed by +3.15%, over one month by +11.71%, over three months by +11.85% and over the past year by +6.36%.
Is MCS a buy, sell or hold?
Marcus has received a consensus analysts rating of 4.75.
Therefore, it is recommended to buy MCS.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.3 | 33.9% |
| Analysts Target Price | 23.3 | 33.9% |
MCS Fundamental Data Overview March 02, 2026
P/E Trailing = 70.125
P/E Forward = 56.1798
P/S = 0.7342
P/B = 1.1377
P/EG = 4.1111
Revenue TTM = 758.5m USD
EBIT TTM = 20.2m USD
EBITDA TTM = 90.4m USD
Long Term Debt = 162.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 222.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 199.4m USD (from netDebt column, last quarter)
Enterprise Value = 726.4m USD (527.0m + Debt 222.8m - CCE 23.4m)
Interest Coverage Ratio = 1.76 (Ebit TTM 20.2m / Interest Expense TTM 11.5m)
EV/FCF = 734.4x (Enterprise Value 726.4m / FCF TTM 989.0k)
FCF Yield = 0.14% (FCF TTM 989.0k / Enterprise Value 726.4m)
FCF Margin = 0.13% (FCF TTM 989.0k / Revenue TTM 758.5m)
Net Margin = 1.67% (Net Income TTM 12.7m / Revenue TTM 758.5m)
Gross Margin = unknown ((Revenue TTM 758.5m - Cost of Revenue TTM -19.5m) / Revenue TTM)
Tobins Q-Ratio = 0.72 (Enterprise Value 726.4m / Total Assets 1.01b)
Interest Expense / Debt = 1.30% (Interest Expense 2.90m / Debt 222.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = 15.9m (EBIT 20.2m * (1 - 21.00%))
Current Ratio = 0.40 (Total Current Assets 64.6m / Total Current Liabilities 163.4m)
Debt / Equity = 0.49 (Debt 222.8m / totalStockholderEquity, last quarter 457.4m)
Debt / EBITDA = 2.21 (Net Debt 199.4m / EBITDA 90.4m)
Debt / FCF = 201.6 (Net Debt 199.4m / FCF TTM 989.0k)
Total Stockholder Equity = 450.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.23% (Net Income 12.7m / Total Assets 1.01b)
RoE = 2.82% (Net Income TTM 12.7m / Total Stockholder Equity 450.5m)
RoCE = 3.29% (EBIT 20.2m / Capital Employed (Equity 450.5m + L.T.Debt 162.0m))
RoIC = 2.54% (NOPAT 15.9m / Invested Capital 628.4m)
WACC = 6.03% (E(527.0m)/V(749.8m) * Re(8.15%) + D(222.8m)/V(749.8m) * Rd(1.30%) * (1-Tc(0.21)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.47%
[DCF] Terminal Value 80.09% ; FCFF base≈10.5m ; Y1≈6.88m ; Y5≈3.14m
[DCF] Fair Price = N/A (negative equity: EV 96.1m - Net Debt 199.4m = -103.3m; debt exceeds intrinsic value)
EPS Correlation: 24.59 | EPS CAGR: 49.41% | SUE: 0.17 | # QB: 0
Revenue Correlation: 34.92 | Revenue CAGR: 10.68% | SUE: 1.30 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.29 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.110 | Chg30d=-0.110 | Revisions Net=-1 | Growth EPS=+2.4% | Growth Revenue=+5.0%
EPS next Year (2027-12-31): EPS=0.71 | Chg7d=-0.048 | Chg30d=-0.048 | Revisions Net=+1 | Growth EPS=+68.2% | Growth Revenue=+2.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 8.2% - Earnings Yield 1.4%)
[Growth] Growth Spread = -3.4% (Analyst 3.4% - Implied 6.7%)
P/E Forward = 56.1798
P/S = 0.7342
P/B = 1.1377
P/EG = 4.1111
Revenue TTM = 758.5m USD
EBIT TTM = 20.2m USD
EBITDA TTM = 90.4m USD
Long Term Debt = 162.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 222.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 199.4m USD (from netDebt column, last quarter)
Enterprise Value = 726.4m USD (527.0m + Debt 222.8m - CCE 23.4m)
Interest Coverage Ratio = 1.76 (Ebit TTM 20.2m / Interest Expense TTM 11.5m)
EV/FCF = 734.4x (Enterprise Value 726.4m / FCF TTM 989.0k)
FCF Yield = 0.14% (FCF TTM 989.0k / Enterprise Value 726.4m)
FCF Margin = 0.13% (FCF TTM 989.0k / Revenue TTM 758.5m)
Net Margin = 1.67% (Net Income TTM 12.7m / Revenue TTM 758.5m)
Gross Margin = unknown ((Revenue TTM 758.5m - Cost of Revenue TTM -19.5m) / Revenue TTM)
Tobins Q-Ratio = 0.72 (Enterprise Value 726.4m / Total Assets 1.01b)
Interest Expense / Debt = 1.30% (Interest Expense 2.90m / Debt 222.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = 15.9m (EBIT 20.2m * (1 - 21.00%))
Current Ratio = 0.40 (Total Current Assets 64.6m / Total Current Liabilities 163.4m)
Debt / Equity = 0.49 (Debt 222.8m / totalStockholderEquity, last quarter 457.4m)
Debt / EBITDA = 2.21 (Net Debt 199.4m / EBITDA 90.4m)
Debt / FCF = 201.6 (Net Debt 199.4m / FCF TTM 989.0k)
Total Stockholder Equity = 450.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.23% (Net Income 12.7m / Total Assets 1.01b)
RoE = 2.82% (Net Income TTM 12.7m / Total Stockholder Equity 450.5m)
RoCE = 3.29% (EBIT 20.2m / Capital Employed (Equity 450.5m + L.T.Debt 162.0m))
RoIC = 2.54% (NOPAT 15.9m / Invested Capital 628.4m)
WACC = 6.03% (E(527.0m)/V(749.8m) * Re(8.15%) + D(222.8m)/V(749.8m) * Rd(1.30%) * (1-Tc(0.21)))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.47%
[DCF] Terminal Value 80.09% ; FCFF base≈10.5m ; Y1≈6.88m ; Y5≈3.14m
[DCF] Fair Price = N/A (negative equity: EV 96.1m - Net Debt 199.4m = -103.3m; debt exceeds intrinsic value)
EPS Correlation: 24.59 | EPS CAGR: 49.41% | SUE: 0.17 | # QB: 0
Revenue Correlation: 34.92 | Revenue CAGR: 10.68% | SUE: 1.30 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.29 | Chg7d=+0.003 | Chg30d=+0.003 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.110 | Chg30d=-0.110 | Revisions Net=-1 | Growth EPS=+2.4% | Growth Revenue=+5.0%
EPS next Year (2027-12-31): EPS=0.71 | Chg7d=-0.048 | Chg30d=-0.048 | Revisions Net=+1 | Growth EPS=+68.2% | Growth Revenue=+2.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.7% (Discount Rate 8.2% - Earnings Yield 1.4%)
[Growth] Growth Spread = -3.4% (Analyst 3.4% - Implied 6.7%)